Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Third Chamber) of 17 September 2019 –  
Pharmadom v EUIPO — IRF (MediWell)

(Case T‑502/18)

(EU trade mark — Opposition proceedings — Application for EU figurative mark MediWell — Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

| 1. | EU trade mark — Definition and acquisition of the EU trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see para. 17) |

| 2. | EU trade mark — Definition and acquisition of the EU trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Similarity of the marks concerned — Criteria for assessment — Composite mark  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 18, 19) |

| 3. | EU trade mark — Definition and acquisition of the EU trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Figurative mark MediWell — Word mark WELL AND WELL and figurative marks well & well LES PHARMACIENS  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 23, 24, 32, 40, 44, 45, 50, 56) |

| 4. | EU trade mark — Definition and acquisition of the EU trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Weighing elements of similarity or difference between the signs — Taking into account of the intrinsic characteristics of the signs or the conditions in which the goods or services are marketed  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see para. 51) |

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 8 June 2018 (Case R 6/2018-5), relating to opposition proceedings between Pharmadom and IRF.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Pharmadom to pay the costs. |

[Top](#document1)